We are pleased to announce that Atida—an international online pharmacy operating in Spain, France, Italy, Germany, the Netherlands, Austria, Portugal, and Belgium—has joined our company, CEPD N.V. CEPD N.V. manages over 1,800 pharmacies, including DOZ S.A. in Poland, Gintarinė Vaistinė and Norfos Vaistinė in Lithuania, and DOZ Apotek in Sweden. Following this integration, CEPD and Atida will offer a broad and complementary range of pharmacy services, supporting the health of patients through both brick-and-mortar and online pharmacy channels.
"This was one of the most fascinating and extraordinary projects I have had the pleasure of leading. Its success would not have been possible without the exceptional commitment of everyone involved—those who were there from start to finish, those who joined along the way, and even those who provided support for just a brief moment. I am incredibly proud to work with a team that approaches even the most complex challenges with such dedication." – emphasizes Mariola Belina-Prażmowska, Vice President of the Management Board of Pelion S.A.
Atida reaches over four million patients. The platform combines professional advice from pharmacists with personalized health recommendations and retail media initiatives, connecting healthcare brands directly with consumers. Atida collaborates with well-known local brands, such as Aponeo, Mifarma, Dosfarma, Santédiscount, and eFarma.

Over the past few years, Atida has worked to become a platform that millions of Europeans rely on for matters related to health and well-being.
In CEPD, it has found a partner that complements its operations by offering in-depth pharmaceutical expertise, operational discipline, and scale in markets where Atida was not previously present.
Following the merger, Atida will continue to operate independently, retaining its existing health brands, management, and strategy. Joost van Hilten remains the CEO of Atida.

The operations of companies within the CEPD group currently reach over 300 million Europeans. By working together, CEPD and Atida can better address patients' needs and accelerate what matters most: leveraging technology and artificial intelligence to make healthcare more personalized, accessible, and affordable for patients across Europe.